Cross-modal in vivo imaging of skin microstructure
Official title: In Vivo Cross-Modal Imaging of Skin - VISION2
Run by Enspectra Health · NCT07188948 · Data updated 2026-11-12
This project will use a handheld imaging device (VIO/FG-30350) to see if microscopic skin features correspond to visible skin appearance in people aged 2 to 90 with different skin health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Years to 90 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Enspectra Health Industry-sponsored |
| Locations | 1 site (Mountain View, California) |
| Status | Recruiting |
| Started | September 2, 2025 |
| Main results expected | September 30, 2025 |
| Study ends | September 30, 2025 |
| Registry record updated | September 23, 2025 |
| Trial ID | NCT07188948 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 2–90 with varying skin health who can provide informed consent (or have a guardian provide consent), comply with protocol visits, and give feedback about device use.
✕Probably not a fit
People seeking therapeutic treatment benefit, those with general health conditions that increase procedural risk, or those unable to consent or comply with protocol procedures are unlikely to receive direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study uses the VIO/FG-30350 device to capture microscopic images of skin at multiple anatomic locations in participants with a range of skin health. Investigators will compare those microscopic features with macroscopic (visible) skin characteristics to identify correlations. Participants aged 2–90 who can consent (or whose guardians can consent) and provide feedback will undergo noninvasive imaging during study visits. Anonymized data will be shared with the sponsor and regulatory bodies for analysis.
Why it matters
Potential benefit: If successful, this could improve noninvasive skin evaluation by linking microscopic imaging patterns to visible clinical signs, aiding earlier and more precise diagnosis or monitoring.
How similar studies have gone: Related noninvasive microscopic skin imaging methods (such as reflectance confocal microscopy and OCT) have clinical precedent, but using VIO/FG-30350 for cross-modal correlation of microscopic and macroscopic features is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants, ages 2 - 90 years old Participant, or guardian, if applicable, must be willing to provide written informed consent prior to enrollment and agree to comply with protocol requirements. If applicable, child must be willing to provide written assent prior to enrollment and agree to comply with protocol requirements. Participant or guardian, if applicable, must have sufficient mental capacity to understand the Informed Consent and provide clinically relevant and reliable feedback regarding their experience with the device. Participant and guardian, if applicable, must comply with the protocol requirements. Participant or guardian, if applicable, must agree that anonymized personal data will be made available to Study Sponsor and requisite regional and international regulatory bodies Exclusion Criteria: Any general health condition or systemic disease that may represent, in the opinion of the Principal Investigator, a potential increased risk associated with device use Currently infected with a communicable skin infection (e.g., shingles or methicillin-resistant S. aureus), which does not include local and minimally pathogenic or non-pathogenic infections distant from the imaging location(s) (e.g., warts, acne) Any known allergies to any materials used in the preparation of skin and/or device use Has a temporary or permanent electrical implanted medical device \-
Where it's running
-
Enspectra Health
Mountain View, California, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Skin Color and Sun Damage: Using AI to Classify Pigmentation and Phototype
Researchers are testing AI-based photo analysis to accurately classify skin pigmentation, phototype, and sun damage in adults to improve skin health risk assessments and care.
-
Western Sweden Systemic Sclerosis Project
This project will collect blood, skin and DNA samples from people with systemic sclerosis in Western Sweden to try to find genes, proteins, and immune changes linked to how the disease starts and gets worse.
-
Beem blue, red, and infrared light therapy for healthier-looking skin
Try a twice-weekly, 20-minute blue, red, and infrared light therapy to see if it improves skin health in eligible U.S. residents.
-
Long-term effects of Ultherapy Prime using multiple depths versus a single 1.5 mm depth for the lower face and neck
This trial will test whether Ultherapy Prime delivered at multiple depths works better than a single 1.5 mm depth to lift, tighten, and smooth the lower face and neck in adults aged 25–65 with moderate to severe skin laxity.
-
Hyaluronic acid plus recombinant collagen volumizing filler for facial wrinkles and sagging
This trial will try a hyaluronic acid and recombinant collagen filler to reduce facial wrinkles, scars, and tissue laxity in non-smoking adults aged 18–70.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.